| Nov 14 |
Vistagen to Present at the Stifel 2024 Healthcare Conference
|
| Nov 10 |
Vistagen Therapeutics, Inc. (VTGN) Q2 2025 Earnings Call Transcript
|
| Nov 8 |
Vistagen Therapeutics Inc (VTGN) Q2 2025 Earnings Call Highlights: Navigating Challenges with a ...
|
| Nov 8 |
VistaGen Therapeutics, Inc. (VTGN) Reports Q2 Loss, Misses Revenue Estimates
|
| Nov 7 |
VistaGen Therapeutics GAAP EPS of -$0.42 misses by $0.03, revenue of $0.18M beats by $0.15M
|
| Nov 7 |
Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update
|
| Nov 6 |
VistaGen Therapeutics Q2 2025 Earnings Preview
|
| Nov 5 |
Vistagen to Present at the 2024 Neuroscience Education Institute Congress
|
| Nov 1 |
Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024
|
| Oct 15 |
Vistagen Could Run Up Ahead Of Phase 3 Results In Social Anxiety Disorder
|
